Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
85 hedge funds and large institutions have $143M invested in Synergy Pharmaceuticals, Inc Common Stock in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 13 closing their positions.
87% more capital invested
Capital invested by funds: $76.2M → $143M (+$66.3M)
58% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 19
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
16% more call options, than puts
Call options by funds: $1.9M | Put options by funds: $1.63M
9% more funds holding
Funds holding: 78 → 85 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$10.1M |
| 2 |
PC
Paulson & Co
New York
|
+$6.81M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.44M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.32M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.15M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$2.97M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$886K |
| 4 |
Morgan Stanley
New York
|
-$807K |
| 5 |
Renaissance Technologies
New York
|
-$494K |
SGYP Hedge Fund Activity: Q1 2015 in Review
85 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q1 2015, worth a combined $143M — up 87% from $76.2M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new SGYP positions and 13 closed out — a net gain of 7 holders — while 30 added to existing stakes and 19 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $10.1M. The largest seller was Fidelity Investments, exiting entirely with an estimated $5.15M sold.
- 85 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q1 2015, up from 78 in Q4 2014.
- Funds reported $143M of Synergy Pharmaceuticals, Inc Common Stock stock for Q1 2015, up 87% quarter-over-quarter.
- 20 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q1 2015 and 13 closed out, a net change of +7 holders.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q1 2015 was OrbiMed, an estimated $10.1M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q1 2015 was Fidelity Investments, an estimated $5.15M sold.
Based on aggregated 13F filings for Q1 2015.